Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 1 (RN7SKP1) is a member of the pseudogene family related to the 7SK small nuclear RNA (snRNA). The true, functional RNA—7SK snRNA—is a non-coding small nuclear RNA that regulates transcription elongation by RNA polymerase II through sequestration of the transcription elongation factor P-TEFb, impacting gene expression, cell differentiation, proliferation, and senescence[2][4][5][1]. However, *RN7SKP1* itself is classified as a **pseudogene**, meaning it is a non-functional genomic remnant related to the active RN7SK gene, typically not transcribed into a functional RNA or protein and lacking direct biological or therapeutic relevance[3]. There is no evidence placing RN7SKP1 as a drug target, biomarker, or causative agent in human diseases. **Note:** - *RN7SKP1* is not a canonical therapeutic target; its association is only with pseudogene status, not active molecular function. - The functional 7SK RNA (not the pseudogene form) participates in regulation of transcription, macrophage polarization, and phagocytic activity, but these biological roles do not extend to RN7SK pseudogenes[1][2][4]. - If the intention was to address the active small nuclear RNA 7SK (RN7SK), see "7SK small nuclear RNA (RN7SK)" for structured target information. **Summary of key points:** - RN7SKP1 is a non-functional pseudogene, not a protein, enzyme, receptor, or RNA with current clinical, diagnostic, or therapeutic implications[3]. - While the genuine RN7SK RNA is an important regulatory non-coding RNA, pseudogene homologs do not share these functions[2][5]. If a functional therapeutic or molecular target was intended, "RN7SK small nuclear RNA" (not the pseudogene) would be the correct entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 1 (RN7SKP1).